Vai al contenuto principale della pagina
| Titolo: |
Allegations of waste, fraud, and abuse in pharmaceutical pricing : financial impacts on federal health programs and the federal taxpayer : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, February 9, 2007
|
| Descrizione fisica: | 1 online resource (iii, 186 p.) : ill |
| Soggetto topico: | Prescription pricing - Corrupt practices - United States |
| Drugs - Prices - United States | |
| Waste in government spending - United States | |
| Soggetto non controllato: | Drugs |
| Waste in government spending | |
| Pricing | |
| Medical | |
| Political science | |
| Business & economics | |
| Altri titoli varianti: | Allegations of waste, fraud, and abuse in pharmaceutical pricing |
| Titolo autorizzato: | Allegations of waste, fraud, and abuse in pharmaceutical pricing ![]() |
| Formato: | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910694354403321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |